These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 2572694)

  • 1. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
    Nishimura T; Kita S; Abiko Y
    J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the sympatholytic action of nebivolol and hypotension.
    Ward JE; Coles P; Cox H; Eisenhofer G; Angus JA
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):115-24. PubMed ID: 1383620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of nebivolol, atenolol and propranolol on heart rate and on bronchoconstrictor responses to histamine in the guinea-pig.
    De Clerck F; Van Gorp L; Loots W; Janssen PA
    Arch Int Pharmacodyn Ther; 1989; 298():230-6. PubMed ID: 2569298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
    Smith HJ; Halliday SE; Earl DC; Stribling D
    J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A; Feely J
    Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation.
    Kubli S; Feihl F; Waeber B
    Clin Pharmacol Ther; 2001 Apr; 69(4):238-44. PubMed ID: 11309552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of nebivolol.
    Janssens WJ
    J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J; Cobo C; Geukens H; Verhaegen H
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoceptors mediating metabolic responses in the greyhound.
    Kelly JG; Shanks RG
    Br J Pharmacol; 1971 Feb; 41(2):389P-390P. PubMed ID: 4396705
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative metabolic and cardiovascular effects of carbuterol, isoproterenol, metaproterenol and salbutamol in the baboon.
    Potter DE; Woodson LC; Kempen RR; Ellis S
    Horm Metab Res; 1980 Jul; 12(7):323-7. PubMed ID: 6105120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
    Ignarro LJ
    Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.
    Van de Water A; Xhonneux R; Reneman RS; Janssen PA
    Eur J Pharmacol; 1988 Oct; 156(1):95-103. PubMed ID: 3208842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nebivolol on cardiovascular changes associated with a rat model of insulin-resistance.
    Renna N; Risler N; Cruzado M; Gonzalez S; Lama C; Miatello RM
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):531-7. PubMed ID: 16309577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise tolerance with nebivolol and atenolol.
    Van Bortel LM; van Baak MA
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.